Showing results (1401-1410 of 1,429) with videos related to

Sort By:
Pageof 143
Journal of Medicinal Chemistry|August 20, 2015
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3Justin K Murray, Yi-Xin Qian, Benxian Liu, et al.
Journal of Alzheimer'S Disease : JAD|September 5, 2017
Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese PopulationLixiao Hao, Xiaoni Wang, Ling Zhang, et al.
The Plant Journal : for Cell and Molecular Biology|February 6, 2022
AhNPR3 regulates the expression of WRKY and PR genes, and mediates the immune response of the peanut (Arachis hypogaea L.)Suoyi Han, Ximeng Zhou, Lei Shi, et al.
Kidney Medicine|August 1, 2020
Development and Validation of Residual Kidney Function Estimating Equations in Dialysis PatientsDominik Steubl, Li Fan, Wieneke M Michels, et al.
ACS Chemical Biology|August 12, 2017
Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx-1 Peptide-Antibody ConjugatesKaustav Biswas, Thomas E Nixey, Justin K Murray, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 13, 2016
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFabHongyan Li, Bingjian Feng, Alexander Miron, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
Nature Communications|February 23, 2026
Single-cell and spatial transcriptomics define 20E-driven developmental reprogramming in silkworm wing discQingsong Liu, Mingmin He, Hao Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2019
Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical SpeciesRobert S Foti, Kaustav Biswas, Jennifer Aral, et al.
Trials|November 11, 2014
Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trialJianhui Qu, Zujiang Yu, Qin Li, et al.
Pageof 143